MedicarePartD.guide

A non-government resource built from CMS public data

TNF blockers on every 2026 Kentucky Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 10 stand-alone Part D plans in Kentucky cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
TNF blockers by 2026 Kentucky Part D plan
DrugHumana Basic Rx Plan$0.00/moS5884-138Wellcare Value Script$8.60/moS4802-150Wellcare Classic$8.70/moS4802-086Humana Value Rx Plan$9.90/moS5884-194SilverScript Choice$29.70/moS5601-030HealthSpring Extra Rx$78.20/moS5617-365AARP Medicare Rx Saver from UHC$90.30/moS5921-360HealthSpring Assurance Rx$117.80/moS5617-222Humana Premier Rx Plan$125.30/moS5884-161AARP Medicare Rx Preferred from UHC$127.10/moS5921-396
HumiraadalimumabNot coveredNot coveredNot coveredNot coveredTier 5PA25%QL 52/365dNot coveredNot coveredNot coveredNot coveredNot covered
adalimumab biosimilarsadalimumab-adaz, -fkjp, -aacf and othersTier 5PA25%QL 0.2/28dTier 5PA25%QL 4/28dTier 5PA25%QL 4/28dTier 5PA26%QL 0.2/28dNot coveredNot coveredTier 5PA25%Not coveredTier 5PA33%QL 0.2/28dTier 5PA31%
Hadlimaadalimumab-bwwdNot coveredNot coveredNot coveredNot coveredTier 5PA25%QL 22.4/365dTier 5PA25%QL 2.4/28dNot coveredTier 5PA25%QL 2.4/28dNot coveredNot covered
Hyrimozadalimumab-adazNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
Cyltezoadalimumab-adbmNot coveredTier 5PA25%QL 4/28dTier 5PA25%QL 4/28dNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
Simlandiadalimumab-ryvkNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
Yuflymaadalimumab-aatyNot coveredTier 5PA25%QL 2/28dTier 5PA25%QL 2/28dNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
Amjevitaadalimumab-attoNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
EnbreletanerceptTier 5PA25%QL 8/28dTier 5PA25%QL 8/28dTier 5PA25%QL 8/28dTier 5PA26%QL 8/28dTier 5PA25%QL 8/28dTier 5PA25%QL 8/28dTier 5PA25%QL 4/28dTier 5PA25%QL 8/28dTier 5PA33%QL 8/28dTier 5PA31%QL 4/28d
Cimziacertolizumab pegolNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
SimponigolimumabNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.